Bicara Therapeutics IPO

Bicara Therapeutics, founded in 2020, is a clinical-stage company striving to develop biologics for cancer patient treatments. Bicara uses tumor-targeting antibodies and the tumor-microenvironment aiming to impact the tumor site for a hardwearing effect. Working to advance cancer treatment for patients who have had difficulty with first- and second-line therapies, Bicara partners with chemistry, manufacturing, and controls (CMC) experts and professional protein engineers who have a history of progressing FDA-approved drugs. Bicara Therapeutics is headquartered in Cambridge, Massachusetts.

Register for Details

For more details on financing and valuation for Bicara Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Bicara Therapeutics

Forge green plus iconForge green minus icon

What is Bicara Therapeutics's IPO price?

The IPO price for Bicara Therapeutics will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Bicara Therapeutics?

Bicara Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Bicara Therapeutics shares pre-IPO?

If you own Bicara Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Bicara Therapeutics a publicly traded company?

Bicara Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Bicara Therapeutics's funding to date?

Bicara Therapeutics has raised $355.03MM to date.
Forge green plus iconForge green minus icon

When was Bicara Therapeutics founded?

Bicara Therapeutics was founded in 2020.

Who are Bicara Therapeutics's major investors?

Premji Invest
Ra Capital Management
F-Prime Capital
Deerfield Management
Janus Henderson Investors
The Invus Group
Aisling Capital
Fairmount Partners
Acorn Bioventures
Bioqube Ventures
Red Tree Venture Capital
Vedanta Capital
Omega Funds

Bicara Therapeutics funding rounds and last known valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation

Series C

$165MM raised $XXX.XX $XXX.XX

Series B

$108.23MM raised $XXX.XX $XXX.XX

Series Seed

$81.79MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Jun 18, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.